177 related articles for article (PubMed ID: 38192634)
21. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
22. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
23. Amorphous Ultra-Small Fe-Based Nanocluster Engineered and ICG Loaded Organo-Mesoporous Silica for GSH Depletion and Photothermal-Chemodynamic Synergistic Therapy.
Li J; Tian H; Zhu F; Jiang S; He M; Li Y; Luo Q; Sun W; Liu X; Wang P
Adv Healthc Mater; 2022 Nov; 11(21):e2201986. PubMed ID: 36106722
[TBL] [Abstract][Full Text] [Related]
24. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
25. Ultrasmall Zwitterionic Polypeptide-Coordinated Nanohybrids for Highly Efficient Cancer Photothermal Ferrotherapy.
Du C; Zhou L; Qian J; He M; Zhang ZG; Feng C; Zhang Y; Zhang R; Dong CM
ACS Appl Mater Interfaces; 2021 Sep; 13(37):44002-44012. PubMed ID: 34494817
[TBL] [Abstract][Full Text] [Related]
26. Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells.
Chen W; Li Z; Yu N; Zhang L; Li H; Chen Y; Gong F; Lin W; He X; Wang S; Wu Y; Ji G
J Nanobiotechnology; 2023 Sep; 21(1):355. PubMed ID: 37775799
[TBL] [Abstract][Full Text] [Related]
27. Anti-Her2 affibody-decorated arsenene nanosheets induce ferroptosis through depleting intracellular GSH to overcome cisplatin resistance.
He P; Xu S; Miao Z; Que Y; Chen Y; Li S; Ma Q; Yang R; Wei W; Zha Z; Hu Y
J Nanobiotechnology; 2023 Jun; 21(1):203. PubMed ID: 37370105
[TBL] [Abstract][Full Text] [Related]
28. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator.
He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL
Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060
[TBL] [Abstract][Full Text] [Related]
29. Single-Atom Cu Nanozyme-Loaded Bone Scaffolds for Ferroptosis-Synergized Mild Photothermal Therapy in Osteosarcoma Treatment.
Yan Z; Wu X; Tan W; Yan J; Zhou J; Chen S; Miao J; Cheng J; Shuai C; Deng Y
Adv Healthc Mater; 2024 Jun; 13(15):e2304595. PubMed ID: 38424663
[TBL] [Abstract][Full Text] [Related]
30. Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy.
Liang Y; Zhang L; Peng C; Zhang S; Chen S; Qian X; Luo W; Dan Q; Ren Y; Li Y; Zhao B
Acta Pharm Sin B; 2021 Oct; 11(10):3231-3243. PubMed ID: 34729312
[TBL] [Abstract][Full Text] [Related]
31. Iron nitroprusside as a chemodynamic agent and inducer of ferroptosis for ovarian cancer therapy.
Asif K; Adeel M; Rahman MM; Caligiuri I; Perin T; Cemazar M; Canzonieri V; Rizzolio F
J Mater Chem B; 2023 Apr; 11(14):3124-3135. PubMed ID: 36883303
[TBL] [Abstract][Full Text] [Related]
32. Mitochondria-targeting graphene oxide nanocomposites for fluorescence imaging-guided synergistic phototherapy of drug-resistant osteosarcoma.
Zeng WN; Yu QP; Wang D; Liu JL; Yang QJ; Zhou ZK; Zeng YP
J Nanobiotechnology; 2021 Mar; 19(1):79. PubMed ID: 33740998
[TBL] [Abstract][Full Text] [Related]
33. Amplified Ferroptosis and Apoptosis Facilitated by Differentiation Therapy Efficiently Suppress the Progression of Osteosarcoma.
He C; Jiang Y; Guo Y; Wu Z
Small; 2023 Nov; 19(44):e2302575. PubMed ID: 37394717
[TBL] [Abstract][Full Text] [Related]
34. Iron-Rich Semiconducting Polymer Dots for the Combination of Ferroptosis-Starvation and Phototherapeutic Cancer Therapy.
Chen M; Yang Y; Tang L; He S; Guo W; Ge G; Zeng Z; Li X; Li G; Xiong W; Wu SX
Adv Healthc Mater; 2023 Oct; 12(26):e2300839. PubMed ID: 37354132
[TBL] [Abstract][Full Text] [Related]
35. Iron plays a role in sulfasalazine-induced ferroptosis with autophagic flux blockage in K7M2 osteosarcoma cells.
Liu J; Lou C; Zhen C; Wang Y; Shang P; Lv H
Metallomics; 2022 May; 14(5):. PubMed ID: 35441682
[TBL] [Abstract][Full Text] [Related]
36. Photothermal and ferroptosis synergistic therapy for liver cancer using iron-doped polydopamine nanozymes.
Li Y; Qian L; Yang Z; Li S; Wu A; Wang X
Colloids Surf B Biointerfaces; 2024 Jul; 239():113911. PubMed ID: 38714079
[TBL] [Abstract][Full Text] [Related]
37. Metal-phenolic networks with ferroptosis to deliver NIR-responsive CO for synergistic therapy.
Li J; Zhou Y; Liu J; Yang X; Zhang K; Lei L; Hu H; Zhang H; Ouyang L; Gao H
J Control Release; 2022 Dec; 352():313-327. PubMed ID: 36272661
[TBL] [Abstract][Full Text] [Related]
38. Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer
Tao W; Wang N; Ruan J; Cheng X; Fan L; Zhang P; Lu C; Hu Y; Che C; Sun D; Duan J; Zhao M
ACS Appl Mater Interfaces; 2022 Feb; 14(5):6404-6416. PubMed ID: 35077153
[No Abstract] [Full Text] [Related]
39. NIR Light-Activated and RGD-Conjugated Ultrasmall Fe/PPy Nanopolymers for Enhanced Tumor Photothermal Ferrotherapy and MR Imaging.
Zhang X; Wang T; Zhou Z; Zhao T; Shen Y; Fang W
Chemistry; 2023 Nov; 29(66):e202302125. PubMed ID: 37673787
[TBL] [Abstract][Full Text] [Related]
40. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
